Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2025-12-26 @ 12:18 PM
NCT ID:
NCT01709500
Group ID:
EG000
Title:
Alirocumab 75 mg/up to 150 mg
Description:
Alirocumab 75 mg SC injection every two weeks (Q2W) added to stable dose of statin with or without LMT for 76 weeks. Alirocumab dose up-titrated to 150 mg Q2W from Week 12 when LDL-C levels ≥70 mg/dL at Week 8.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
10
Serious Number At Risk:
167
Other Number Affected:
65
Other Number At Risk:
167
Study:
NCT01709500
Results Section:
NCT01709500
Adverse Events Module:
NCT01709500